Related Experiment Video
Updated: Sep 10, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
How Can We Reduce Cardiovascular Risk in Women and Improve Risk Stratification?
Fabiana Hanna Rached1, Viviane Zorzanelli Rocha2, Thales Fraga Ferreira da Silva2
1Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil. fabianarached@gmail.com.
Cardiovascular disease (CVD) disproportionately affects women, with persistent disparities in care. Sex-specific risk factors and tailored prevention strategies are crucial to improve outcomes and close the care gap.
Area of Science:
- Cardiology
- Sex-Based Health Disparities
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality globally.
- Significant sex-based disparities exist in CVD awareness, diagnosis, and treatment.
- Women present unique biological and psychosocial risk factors often overlooked in standard assessments.
Purpose of the Study:
- To evaluate the burden of CVD in women versus men.
- To determine if CVD risk factors differ between sexes in prevalence, impact, and prognosis.
- To assess the need for sex-specific risk stratification and earlier preventive strategies in women.
Main Methods:
- This review synthesizes current data on sex-specific dimensions of cardiovascular disease.
- It addresses the prevalence, risk factors, and prognostic significance of CVD in women compared to men.
- The review examines the utility of sex-specific risk stratification tools and preventive strategies.
Main Results:
- CVD remains the primary cause of morbidity and mortality in women worldwide.
- Sex-based disparities in CVD care persist despite medical advancements.
- Underrecognized, female-specific risk factors necessitate tailored approaches.
Conclusions:
- A sex-sensitive approach to CVD prevention and management is essential.
- Developing sex-specific risk tools and earlier interventions can improve outcomes for women.
- Revising traditional risk frameworks to include female-specific factors is key to closing the care gap.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

